Send to a Friend Font Size: Increase Decrease

PVLA and ARQT Related Headlines

Sep 3, 2025 07:30AM Palvella Therapeutics Strengthens Leadership with Appointment of Accomplished Scientist and Biopharmaceutical Executive David W. Osborne, Ph.D. as Chief Innovation Officer

PVLA and ARQT Related Press Releases

Sep 3, 2025 07:30AM Palvella Therapeutics Strengthens Leadership with Appointment of Accomplished Scientist and Biopharmaceutical Executive David W. Osborne, Ph.D. as Chief Innovation Officer

PVLA and ARQT Related SEC Filings